PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
September 10, 2025International Journal of Medical and All Body Health Research

Comparison of Two Doses of Dexmedetomidine as an Adjuvant to Bupivacaine 0.5% in USG Guided Supraclavicular Brachial Plexus Block: A Double Blind Randomised Controlled Study

View Full Paper
Ask AI
Bookmark
Share

Authors

MTManoj TanwarSSShailja SharmaSLSanjay Kumar Lal

Discussion

Loading...

Member takes

Overview

Double-blind study shows dexmedetomidine enhances sensory and motor blockade in patients, suggesting better analgesia.

Key Points

  • Dexmedetomidine 1.0 μg/kg enhances the duration of sensory and motor blockade compared to control.
  • Results show both dexmedetomidine doses significantly improve postoperative analgesia duration and patient satisfaction scores.
  • Randomized controlled trial with 90 patients evaluated the effects of two dexmedetomidine doses in regional anesthesia.
  • Enhanced analgesic effects may come at the cost of higher incidence of sedation and bradycardia in the higher dose group.

Cite This Study

Tanwar et al. (2025) studied this question.

synapsesocial.com/papers/68c1b34d54b1d3bfb60e9b12https://doi.org/10.54660/ijmbhr.2025.6.3.171-177
View Full Paper
Ask AI
Bookmark
Share